Abstract
This chapter provides an overview of telemedicine in Japan. Although the COVID-19 pandemic gave it a strong boost, traditional face-to-face interactions with physicians are still the norm. Hurdles for further growth include Japan’s old population and lower reimbursement rates for telemedicine compared to face-to-face medical care. On the other hand, Japan is one of the few countries in the world where digital apps are reimbursable by statutory health insurance given a positive scientific and economic evaluation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akematsu Y, Tsuji M. Measuring the effect of telecare on medical expenditures without bias using the propensity score matching method. Telemed J E Health 2012;18(10):743-747.
Akematsu Y, Nitta S, Morita K, Tsuji M. Empirical analysis of the long-term effects of telecare use in Nishi-aizu Town, Fukushima Prefecture, Japan. Technol Health Care 2013;21(2):173-182.
Akiyama M, Yoo BK. A Systematic Review of the Economic Evaluation of Telemedicine in Japan. J Prev Med Public Health. 2016;49(4):183-96.
Bolt T, Kobayashi H, Mahlich J. Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan. PharmacoEconomics Open 2019;3, 255–264.
Broens T, Huis in’t Veld R, Vollenbroek-Hutten M, Hermens H, van Halteren A, Nieuwenhuis L. Determinants of successful telemedicine implementations: A literature study. J Telemed Telecare. 2007;13:303–309.
Cassel D, Mahlich J. What shapes the pharmaceutical market in Japan? Institutional Framework and Challenges of the Japanese Drug Industry, in: Storz C, Taube M (Eds.): Firms, Institutions, and the State in East Asia, Marburg: Metropolis, 2020: 137-151.
Central Social Medical Insurance Council (Chuikyo), The 422nd session, [in Japanese], Tokyo 2019a, available: https://www.mhlw.go.jp/content/12404000/000638093.pdf
Central Social Medical Insurance Council (Chuikyo), The 416th session, [in Japanese], Tokyo 2019b, available: https://www.mhlw.go.jp/stf/shingi2/0000205879_00062.html
Chen J, Lan Y-C, Chang Y-W, Chang P-Y. Exploring doctors’ willingness to provide online counseling services: The roles of motivations and costs. Int J Environ Res Public Health. 2020;17:110.
Cureapp, Inc. (n.d.) https://cureapp-en.blogspot.com/2020/12/cureapp-sc-digital-therapeutic-for.html
Deutsches Ärzteblatt. Arztbesuche: Fallzahlen in Bayerns Praxen zurückgegangen, May 19th, 2020, available: https://www.aerzteblatt.de/nachrichten/113010/Arztbesuche-Fallzahlen-in-Bayerns-Praxen-zurueckgegangen
Gerke S, Stern A, Minssen T. Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries. npj Digit Med 2020;3:94.
Hafner P, Mahlich J. Determinants of physician’s office visits and potential effects of co-payments: evidence from Austria. Int J Health Plann Manage 2016;31(3):e192–e203.
Hasegawa M, Komoto S, Shiroiwa T, Fukuda T. Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System. Value Health 2020;23(1), 43–51.
Ito J, Edirippulige S, Aono T, Armfield NR. The use of telemedicine for delivering healthcare in Japan: Systematic review of literature published in Japanese and English languages. J Telemed Telecare 2017;23(10):828-834
Japan Medical Association General Policy Research Organization. Current status of online medical care [in Japanese], Tokyo 2020, available: https://www.jmari.med.or.jp/download/RE080.pdf
Kaneko K, Nakagawa I. With apps and remote medicine, Japan offers glimpse of doctor visits in post-corona era, London: Reuters 2020, available: https://www.reuters.com/article/us-health-coronavirus-japan-telehealth-idUSKBN24A01K
Kario K, Nomura A, Harada N, Tanigawa T, So R, Nakagawa K, Suzuki S, Okura A, Hida E, Satake K. A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trial. J Clin Hypertens 2020;22:1713-1722.
Mahlich J. Die japanische Pharmaindustrie, in: Moerke, A., Walke, A. (eds.), Japans Zukunftsindustrien, Heidelberg: Springer 2007, 103-123.
Mahlich J, Sruamsiri R. Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach. Int J Equity Health 2019;18:13.
Mahlich J, Kamae I, Rossi B. A new Health Technology Assessment System for Japan? Simulating the Potential Impact on the Price of Simeprevir. Int J Technol Assess Health Care 2017;33(1):121-127.
Mahlich J, Dilokthornsakul P, Sruamsiri R, Chaiyakunapruk N. Cultural beliefs, utility values, and health technology assessment. Cost Eff Resour Alloc 2018,16, 19.
Masaki K, Tateno H, Kameyama N, Morino E, Watanabe R, Sekine K, Ono T, Satake K, Suzuki S, Nomura A, Betsuyaku T, Fukunaga K. Impact of a Novel Smartphone App (CureApp Smoking Cessation) on Nicotine Dependence: Prospective Single-Arm Interventional Pilot Study. JMIR Mhealth Uhealth 2019;7(2):e12694.
Masaki K, Tateno H, Nomura A, Muto T, Suzuki S, Satake K, Hida E, Fukunaga K. A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker. npj Digit Med 2020;3(1):35.
Medical Practitioners’ Act, Article 20 [in Japanese], Tokyo 1948
Ministry of Health, Labor and Welfare, The 10th Study Group on Review of Guidelines for Proper Implementation of Online Medical Care [in Japanese], Tokyo 2020, available: https://www.mhlw.go.jp/stf/newpage_12769.html
Ministry of Health, Labor and Welfare, A notification from a bureau of MHLW [in Japanese], Tokyo 1997, available: https://www.mhlw.go.jp/bunya/iryou/johoka/dl/h23.pdf
Ministry of Health, Labor and Welfare, Homepage about medical insurance system [in Japanese], Tokyo 2020, available: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iryouhoken/iryouhoken01/index.html
Ministry of Health, Labor and Welfare, Medical insurance, Tokyo 2020, available: https://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken01/dl/01_eng.pdf
Muramatsu N, Akiyama H. Japan: Super-Aging Society Preparing for the Future. Gerontologist 2011;51(4): 425–432.
Muto T, Tanigawa T, Nomura A, Ogawa T, Ikeda S, Satake K. Cost-Effectiveness Analysis of Digital Therapy for the Patients with Nicotine Dependence. Japanese Journal of Telemedicine and Telecare 2019;15 (1):
Narasimha S, Madathil KC, Agnisarman S, et al. Designing telemedicine systems for geriatric patients: a review of the usability studies. Telemed J E Health 2017; 23: 459–472
Nicolaisen M, Thorsen K. Who are lonely? Loneliness in different age groups (18–81 years old), using two measures of loneliness. Int J Aging Hum Dev. 2014;78:229–57.
Nikkei Online [in Japanese]. Tokyo 2020, available: https://www.nikkei.com/article/DGXMZO64830130Z01C20A0EA3000
Nisseikiso Research Institute. Re-questioning the debate over online medical care-a perspective that is not bound by the pros and cons of the first-time face-to-face principle, Tokyo 2020, available: https://www.nli-research.co.jp/report/detail/id=64672&pno=2?site=nli
Nomura A, Tanigawa T, Muto T, Oga T, Fukushima Y, Kiyosue A, Miyazaki M, Hida E, Satake K. Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial. J Med Internet Res 2019;21(4):e13520.
OECD 2018. Doctors’ consultations (indicator). https://doi.org/10.1787/173dcf26-en.
Reich M, Ikegami N, Shibuya K, Takemi K. 50 years of pursuing a healthy society in Japan. Lancet 2011;378(9796):1051-1053.
Schaarschmidt ML, Schmieder A, Umar N, et al. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Arch Dermatol. 2011;147(11):1285–94
Stern A, Matthies H, Hagen J, Brönneke J, Debatin J. Want to See the Future of Digital Health Tools? Look to Germany. Harv Bus Rev 2020, December 2.
Synodinos N. Understanding Japanese consumers: some important underlying factors. Jpn Psychol Res. 2001;43(4):235–48.
Tofukuji T. Definition and Typing of Telemedicine - What is telemedicine? In: Japan Telemedicine and Telecare Association (Ed.): Telemedicine in Japan. Tokyo, 2013, available: http://jtta.umin.jp/pdf/telemedicine/telemedicine_in_japan_20131015-2_en.pdf
van den Broek T. Gender differences in the correlates of loneliness among Japanese persons aged 50–70. Australas J Aging. 2017;36(3):234–7.
van Houwelingen CT, Moerman AH, Ettema RG, Kort HS, Ten Cate O. Competencies required for nursing telehealth activities: a Delphi-study. Nurse Educ Today 2016;39:50-6
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Demiya-Dillenburger, S., Isshiki, M., Mahlich, J. (2022). Telemedicine in Japan: Challenges and Opportunities. In: Walzer, S. (eds) Digital Healthcare in Germany. Contributions to Economics. Springer, Cham. https://doi.org/10.1007/978-3-030-94025-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-94025-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94024-9
Online ISBN: 978-3-030-94025-6
eBook Packages: Economics and FinanceEconomics and Finance (R0)